LISTED AMERICAN MANUFACTURERS

Advanced Prosthetics and Orthotics of New Mexico stands as a premier healthcare provider specializing in custom prosthetic and orthotic solutions throughout Albuquerque and Santa Fe. With multiple locations including Central Albuquerque, West Albuquerque, and Santa Fe, the company delivers comprehensive mobility solutions tailored to enhance comfort, independence, and quality of life for patients of all ages. The company excels in creating personalized prosthetic devices, custom orthotics, and specialized pediatric care, utilizing advanced technology and precision craftsmanship to meet each individual patient needs. Their expertise extends to athletic prosthetics, supporting active individuals and athletes in achieving their performance goals. Advanced Prosthetics and Orthotics offers unique in-home rural care services, ensuring accessibility for patients across New Mexico challenging geographical landscape. Operating under the philosophy that "Everything Is Everything," the company maintains a patient-first approach, emphasizing attention to detail in every aspect of care delivery. Their comprehensive services include soft goods and specialized mobility solutions designed to restore independence and build confidence. The experienced team combines groundbreaking innovation with expert clinical care, establishing the company as a trusted leader in prosthetic and orthotic manufacturing throughout the southwestern healthcare market.

Armonica Technologies is an innovative biotechnology company based in Albuquerque, New Mexico, specializing in advanced DNA sequencing technology for precision medicine applications in the healthcare industry. Founded in 2017, the company has developed proprietary optical nanopore sequencing technology that uses specialized nanochannels to deliver long, single DNA molecules through nanopores, where characteristic optical signatures are read using Surface Enhanced Raman Spectroscopy. This breakthrough approach enables faster, more thorough, and more accurate genomic analysis compared to traditional sequencing methods, without requiring extensive workflows and reagents. The company focuses on detecting essential epigenomic data that conventional genomics techniques cannot identify, positioning their technology as a game-changer for personalized medicine and cancer treatment diagnostics. Armonica Technologies has secured significant funding including a two million dollar grant from the National Institutes of Health and backing from multiple investors including the National Human Genome Research Institute, Cottonwood Technology Fund, and Sun Mountain Capital. While still transitioning from research to commercial manufacturing, the company works closely with the University of New Mexico to scale their innovative fabrication processes for mainstream production.

BennuBio is an innovative healthcare technology company based in Albuquerque, New Mexico, specializing in advanced flow cytometry solutions for biological research and drug discovery. The company develops cutting-edge analytical equipment designed to revolutionize 3D multicellular model system analysis with unprecedented analytical throughput and biological insight capabilities. BennuBio flagship product, the Velocyt system, enables rapid analysis of intact spheroids and organoids, delivering results 100 times faster than traditional methods. This breakthrough technology supports diverse applications including drug discovery research, C. elegans analysis, and bioprocessing operations. The system processes flexible sample volumes from microliters to milliliters while preserving sample physiology and viability, eliminating the need for time-consuming washing and enrichment steps. The company serves pharmaceutical companies, research institutions, and biotechnology organizations seeking enhanced analytical capabilities for complex biological models. BennuBio commitment to innovation extends through comprehensive technical support, including white papers, technical notes, and published research that demonstrate real-world applications and validation data. Located in the growing biotechnology corridor of New Mexico, BennuBio combines advanced engineering expertise with deep biological knowledge to deliver solutions that accelerate research timelines and improve experimental outcomes for customers worldwide.

Colorcon is a leading global manufacturer specializing in pharmaceutical excipients, film coating systems, and controlled release technologies, headquartered in Belen, New Mexico. With over 60 years of industry expertise, the company serves the healthcare sector by providing innovative solutions for pharmaceuticals, nutraceuticals, dietary supplements, and animal health products. Colorcon offers comprehensive product development support through its core excipient technologies, advanced film coating systems, controlled release formulations, and controlled atmosphere packaging solutions. The company partners with clients from concept to commercialization, ensuring rapid product development and market entry through technical collaboration and quality manufacturing processes. Colorcon maintains a strong commitment to sustainability and innovation, delivering specialized excipient solutions that enhance product stability, patient compliance, and manufacturing efficiency. Their global manufacturing capabilities and technical expertise enable pharmaceutical companies to overcome formulation challenges and achieve optimal product performance. The company focuses on providing strategic partnerships that accelerate time-to-market while maintaining the highest quality standards in pharmaceutical manufacturing and excipient production.

Indica Labs is a cutting-edge healthcare technology company based in Albuquerque, New Mexico, specializing in AI-powered pathology solutions and advanced image analysis software. The company has established itself as a leader in quantitative digital pathology through its flagship HALO software suite, which delivers unmatched ease-of-use and scalability for organizations worldwide. HALO provides high-throughput tissue analysis capabilities with the fastest processing speeds available in digital pathology image analysis, enabling researchers and diagnosticians to conduct comprehensive pathological research with unprecedented efficiency. From discovery to diagnostics, Indica Labs integrates artificial intelligence throughout their entire software platform and services, offering powerful analytic capabilities that transform how medical professionals approach tissue analysis and diagnostic workflows. The company serves healthcare organizations, research institutions, and diagnostic laboratories seeking advanced solutions for pathology research and clinical applications. With a focus on innovation and technological excellence, Indica Labs continues to push the boundaries of what is possible in AI-driven medical imaging and analysis, providing tools that enhance diagnostic accuracy and accelerate medical research discoveries.

Nob Hill Therapeutics is an innovative healthcare technology company based in Albuquerque, New Mexico, dedicated to revolutionizing respiratory medicine through advanced inhalation delivery systems. The company operates with a clear mission to improve patients' lives by re-envisioning inhalation medicines and how they are delivered to the lungs, focusing specifically on changing the treatment paradigm for high-dose lung delivery. As part of the VIC Technology Venture Development ecosystem, Nob Hill Therapeutics combines cutting-edge technology development with pragmatic therapeutic solutions for respiratory patients. The company specializes in developing new technologies and therapies for lung-related diseases, positioning itself at the forefront of respiratory healthcare innovation. Located at 5901 Indian School Road in Albuquerque, the organization operates under five core values that drive their approach: delivering results, acting pragmatically, moving fast, trusting and supporting each other, and doing the right thing. This value-driven approach enables them to develop breakthrough inhalation medicine technologies that address critical unmet needs in respiratory patient care. Nob Hill Therapeutics represents the next generation of therapeutic companies that leverage technology-driven solutions to transform traditional treatment approaches, making significant advances in lung delivery systems and respiratory medicine for improved patient outcomes.

Samuel Weisberg Prosthetics stands as Albuquerque's longest-established prosthetic company, delivering exceptional custom prosthetic and orthotic solutions for over three decades. Located in New Mexico's healthcare corridor, this specialized healthcare manufacturing facility combines traditional craftsmanship with modern technology to create lightweight, durable, and cosmetically appealing prosthetic devices tailored to each patient's unique needs. The company specializes in comprehensive prosthetic services including custom limb solutions for all body types, specialized orthotic devices, and custom bracing systems. Their experienced team develops in-house custom plans for each client, ensuring optimal fit, function, and comfort. Samuel Weisberg Prosthetics serves diverse patient populations, from individuals recovering from accidents to athletes requiring specialized sports injury solutions. What distinguishes this Albuquerque-based manufacturer is their patient-centered approach, offering free consultations and personalized care plans. Their facility on Coal Avenue Southeast has become a trusted resource for healthcare professionals and patients throughout New Mexico and the Southwest region. The company maintains rigorous quality standards while providing compassionate care, understanding that each prosthetic device represents not just advanced medical manufacturing, but a pathway to restored mobility and independence for their clients.

Sandia Biotech is an innovative biotechnology company based in Albuquerque, New Mexico, specializing in advanced fluorescent reagent development for the healthcare industry. The company has established itself as a leader in molecular imaging technology, developing cutting-edge FluorAbody technology that revolutionizes biomarker detection and quantification. Sandia Biotech offers sophisticated protein analysis products, including Split-Fluorescent Protein and proprietary FluorAbody technologies that provide researchers with unprecedented accuracy in biological assays. Their FluorAbodies feature a unique 1:1 fluorophore to epitope ratio, enabling true quantitation of biomarkers while preventing cross-linking of target molecules. This innovative approach significantly streamlines laboratory workflows by eliminating secondary antibody steps and shortening staining protocols. The company serves the research community with particular expertise in cancer research applications, providing scientists with tools that accelerate discovery and enhance analytical precision. Sandia Biotech offers partnership opportunities and OEM deals, making their advanced technologies accessible to laboratories, pharmaceutical companies, and research institutions worldwide. Their commitment to developing next-generation molecular imaging solutions positions them as a valuable partner for organizations seeking to advance their bioanalytical capabilities and drive scientific innovation in healthcare research.

Specifica, a cutting-edge antibody discovery and development company based in Santa Fe, New Mexico, operates as part of IQVIA Laboratories to deliver advanced healthcare solutions through innovative biotechnology manufacturing. The company specializes in next-generation antibody libraries and comprehensive discovery services, serving pharmaceutical companies, biotech firms, and academic research institutions worldwide. Specifica's Generation 3 antibody platform demonstrates exceptional performance metrics, with 60% of antibodies achieving affinities below 10nM and 20% reaching subnanomolar levels, while over 80% exhibit no measurable biophysical liabilities. Their manufacturing capabilities encompass antibody libraries, discovery campaigns, AI antibody data packages, R&D services, reagents, and VHH single domain antibody libraries. The company leverages machine learning-powered antibody clustering and exclusive, customizable library designs to ensure diverse epitope coverage and rapid discovery processes. Specifica's integrated selection pipeline combines advanced AI technology with straightforward collaboration terms, enabling full platform transfer options for clients. Their drug-like antibodies offer superior quality and performance characteristics, positioning the company as a leader in biotechnology manufacturing and antibody development services within the healthcare industry.

T-NeuroDx, based in Albuquerque, New Mexico, is an innovative healthcare company revolutionizing Alzheimer's disease diagnostics through groundbreaking biomarker research. Operating under the mission of "Diagnosing Alzheimer's Before It's Too Late," the company is commercializing a diagnostic test for hiT cells, a newly discovered biomarker that initiates Alzheimer's pathology. Led by Co-Founder and Chief Science Officer Dr. Christopher Wheeler, T-NeuroDx has pioneered research demonstrating that aged, self-reactive T cells migrate from peripheral blood to the brain early in disease progression, triggering Alzheimer's pathology in animal models. This breakthrough represents the first identified biomarker that initiates Alzheimer's in an animal model, positioning the company at the forefront of early detection technology. Unlike traditional approaches that target visible symptoms, T-NeuroDx focuses on the root cause of disease initiation, offering healthcare providers and patients a more sensitive and earlier detection method. Their innovative diagnostic capabilities address the critical need for early intervention in Alzheimer's treatment, potentially improving patient outcomes through timely diagnosis. Located at Innovation Parkway in Albuquerque's technology corridor, T-NeuroDx combines cutting-edge scientific research with practical diagnostic applications, advancing the future of neurological healthcare through precision medicine and biomarker innovation.